InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Jacobs Bruce N., Chief Financial Officer. Officer active across 2 companies, notably Kymera Therapeutics, Inc.. Aggregated, 19 disclosures have been logged. Activity tracked since 3 June 2021. The latest transaction was filed on 2 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Jacobs Bruce N.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
17,650 shares0Common StockSEC:0001193125-26-091982:0
79,220 shares@ US$2.0829.4% of flowCommon StockSEC:0001193125-25-206350:0
25,000 shares@ US$2.0814.3% of flowCommon StockSEC:0000950170-25-048049:0
30,000 shares0Common StockSEC:0000950170-25-031146:0
10,000 shares@ US$2.086.0% of flowCommon StockSEC:0000950170-25-004548:0
25,000 shares@ US$2.0814.5% of flowCommon StockSEC:0000950170-24-078790:0
31,250 shares0Common StockSEC:0000950170-24-025083:0
10,000 shares@ US$2.085.8% of flowCommon StockSEC:0000950170-23-025989:0
23,750 shares0Common StockSEC:0000899243-23-006979:0
10,000 shares@ US$2.086.3% of flowCommon StockSEC:0000899243-22-033996:0
10,000 shares@ US$2.086.3% of flowCommon StockSEC:0000899243-22-033710:0
20,000 shares@ US$2.080.0006% mcap25.2% of flowCommon StockSEC:0000899243-22-016429:0
13,300 shares0Common StockSEC:0000899243-22-009078:0
15,000 shares@ US$2.085.8% of flowCommon StockSEC:0000899243-22-002010:0
10,000 shares@ US$2.083.8% of flowCommon StockSEC:0000899243-22-002016:0
10,000 shares@ US$2.083.9% of flowCommon StockSEC:0000899243-21-046845:0
10,000 shares@ US$2.083.9% of flowCommon StockSEC:0000899243-21-045803:0
10,000 shares@ US$2.083.7% of flowCommon StockSEC:0000899243-21-035158:0
10,000 shares@ US$2.083.6% of flowCommon StockSEC:0000899243-21-022025:0
19 of 19 declarations
About Jacobs Bruce N.
Jacobs Bruce N. is Directeur Financier and Chief Financial Officer of Kymera Therapeutics, Inc. He has 19 filings in total, and in the sampled recent filings the most frequent transaction nature is option exercise, with a period from 2021-06-04 to 2026-03-04 and buy and sell amounts shown as EUR 0 each.
